AANA Journal: Efficacy and Safety Of Buprenorphine in a Single-Shot Peripheral Nerve Block: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Catalog

Create Account

Availability

On-Demand

Expires on Mar 18, 2027

Cost

$0.00

Credit Offered

2 Class A Credits

2 Pharmacology Credits

Lack of evaluation of the efficacy and safety of buprenorphine as an LA additive in prolonging the duration of analgesia.

Unrelieved postoperative pain remains a significant patient issue resulting in physical or psychological changes that leads to increased morbidity and mortality, increased costs, and a decrease in quality of life. The use of local anesthetics (LAs) in peripheral nerve blocks (PNBs) provides better analgesia than opioids alone; however, adequate pain relief in the early postoperative period is limited by the duration of action of the LA. While it is possible to place a catheter for postoperative pain management, catheter placement requires technical skills, additional time, and resources. Additionally, catheter placement may create unintended problems such as inaccurate catheter tip placement resulting in block failure, catheter knotting, an increased risk of infection, and neurologic complications. Hence, anesthesia providers seek to extend the benefits of single-shot PNB using LA additives.

The anesthesia provider is equipped with the knowledge to use buprenorphine as an effective adjunct in extending analgesia and mitigating pain scores and opioid usage when appropriate.

Learning Outcomes:

Explore the safety and effectiveness of buprenorphine in prolonging analgesia in single-injection peripheral nerve blocks.

Understand the impact that buprenorphine has on a patient’s pain scores, opioid consumption, and PONV.

April Cook, DNAP, CRNA
Tito D. Tubog, PhD, DNAP, CRNA
William Johnson, DNAP, CRNA
Hallie Evans, DNP, CRNA, APRN, CNE

Accreditation Information:
The American Association of Nurse Anesthesiology is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.

Disclosure Statement:
Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Post-Test Attempt Notice:
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:
The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthesiology.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthesiology has no responsibility or liability for the accuracy or completeness of the content.

Refund Policy:
Continuing education activities are nonrefundable.